FUNDING APPROVED FOR ALL REMAINING RECOMMENDED PROPOSALS FROM ROUND 9
Author:
Bernard Rivers
Article Type:Article Number: 1
ABSTRACT The Global Fund Board has now approved funding for 31 Round 9 proposals that had been recommended by the Technical Review Panel, but for which formal approval was delayed because sufficient funds were not available.
The Global Fund Board has approved funding for 31 Round 9 proposals that had been recommended by the Technical Review Panel (TRP), but for which funding was not formally approved at the Board’s in-person meeting in November 2009.
At the time of the Board meeting, the Global Fund did not have enough money to approve all 85 proposals recommended by the TRP. Consequently, the Board formally approved all 54 proposals rated Category 1 or Category 2, but approved only “in principle” the 31 proposals rated Category 2B.
The 31 proposals will cost $720 million over the first two years. This amount is prior to the “efficiency savings” (i.e., cost-cutting) mandated by the Board for all approved Round 9 proposals. These savings should amount to at least 10% of the $720 million total, though the percentage reduction for individual grants will vary.
The Global Fund said that additional funding sufficient to approve the 31 proposals came from several sources, in particular confirmation of additional pledges by some donors; and a reduction in the amounts forecasted to be required for Phase 2 and rolling continuation channel (RCC) renewals in 2010.
Of the 31 proposals formally approved by the Board, 29 were from CCMs and two were from regional organisations. The proposals are listed in the following table.
| Applicant | Component | Applicant | Component | |
| FROM CCMS | Montenegro | HIV | ||
| Angola | TB | Mozambique | HIV (disease part) | |
| Belize | HIV (disease part + HSS part) | Nicaragua | Malaria | |
| Bosnia & Herzegovina | TB | Nigeria | TB | |
| Central African Republic | TB | Sri Lanka | HIV (disease part + HSS part) | |
| China | TB (disease part + HSS part) | Tanzania | Malaria | |
| Columbia | HIV | Turkmenistan | TB (disease part) | |
| Congo (Democratic Republic of) | TB (disease part + HSS part) | Vietnam | TB | |
| Congo (Republic of) | HIV | Yemen | TB | |
| Djibouti | Malaria | FROM REGIONAL ORGANISATIONS | ||
| Ethiopia | TB (HSS part) | COPRECOS LAC (re Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela) | HIV | |
| Gambia | TB | |||
| Guinea-Bissau | TB | |||
| Haiti | TB | |||
| India | HIV | |||
| India | Malaria | |||
| Iraq | TB | SADC (re Angola, Botswana, Congo (Democratic Republic), Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland , United Republic of Tanzania, Zambia, Zimbabwe) | HIV | |
| Kenya | TB | |||
| Kosovo | TB | |||
| Kyrgyz Republic | TB | |||
| Moldova | TB | |||
For information on the budgets of individual proposals, see “Round 9 results, by country” in GFO Issue 110 at www.aidspan.org/gfo.
